期刊文献+

丙戊酸钠对Kasumi-1细胞裸鼠移植瘤的生长抑制作用及机制探讨 被引量:5

Inhibitory effect of valproic acid on xenografted Kasumi-1 tumor growth in nude mouse and its mechanism
原文传递
导出
摘要 目的研究组蛋白脱乙酰化酶(HDAC)抑制剂丙戊酸钠(VPA)体内给药对白血病细胞系Kasumi-1细胞裸鼠移植瘤生长的影响,探讨可能的作用机制。方法建立Kasumi-1细胞裸鼠移植瘤模型,分为对照组和VPA治疗组进行实验,观察并记录各组裸鼠移植瘤的生长情况,计算肿瘤体积和肿瘤生长抑制率。HE染色观测肿瘤细胞形态。采用末端脱氧核糖核酸转移酶介导的dUTP原位缺口末端标记(TUNEL)法检测肿瘤细胞凋亡。RT—PCR和Western blot方法分析粒-单核细胞集落刺激因子(GM—CSF)、组蛋白脱乙酰化酶1(HDAC1)、乙酰化组蛋白H3(Ac—H3)、Survivin mRNA或蚩白的表达。染色质免疫共沉淀(ChIP)法检测VPA对GM—CSF基因启动子区域染色质内组蛋白H3乙酰化程度的影响。结果①VPA体内用药明显抑制裸鼠Kasumi—1细胞移植瘤的生长,VPA治疗组肿瘤体积及重量与对照组相比明显缩小或降低,瘤体抑制率(IR)为57.25%。②HE染色可见肿瘤细胞分化及凋亡程度增加,凋亡指数VPA组[(3.66±0.77)%]与对照组[(0.27±0.11)%]相比明显升高。③与对照组比较,VPA治疗组胞核内HDAC1蛋白表达水平明显降低,Ac—H3蛋白表达水平明显升高;GM—CSFmRNA和蛋白表达水平明显升高;GM—CSF启动子区域染色质内组蛋白H3的乙酰化程度明显升高;Survivin的mRNA表达水平明显降低。结论VPA对Kasumi—1细胞裸鼠移植瘤有明显的生长抑制作用,诱导肿瘤细胞分化及凋亡,其机制可能与通过抑制SmMvin基因表达诱导细胞凋亡,和通过抑制细胞核内HDAC表达,增强组蛋白乙酰化程度,影响GM—CSF基因启动子区域染色质内的组蛋白乙酰化修饰,增加AMLI靶基因GM—CSF的转录诱导细胞分化有关。 Objective To investigate in vivo inhibitory effect of histone deacetylase (HDAC) iuhibitor valpruic acid(VPA) on xenografted Kasumi-1 tumor in nude mice and its mechanism. Methods Xeno- grafted Kasumi-1 tumor mouse model was established by subcutaneous inoculation of Kasumi-1 cells. Xenotransplanted nude mice were assigned into control or VPA treatment groups. Volume of the xenografted tmnors was measured and compared between the two groups. Terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling (TUNEL) was applied to detection of tumor cell apoptosis. The gene expression of (,M-CSF, HDACI ,Ac-H3 and survivin was studied with semi-quantitative RT-PCR and Western blotting. ChIP method was used to assay the effects of VPA on acetylation of histone H3 within GM-CSF promoter region. Results (1)VAP significantly inhibited xenografted Kasumi-1 tumor growth. The calculated inhibition rate was 57.25%. (2)Morphologic study showed that VPA induced differentiation and apoptosis of Kasumi-1 tumor cells. The apoptosis index of VAP treatment group [ ( 3.661 ± 0. 768) % 1 was significantly higher than that of control group [ (0. 267± 0.110)% ]. (3)Compariug to those in control group, the level of nuclear HDACI protein was significantly decreased, the Ac-H3 protein expression level was increased, the mRNA and protein expression levels of GM-CSF and acetylation of histone H3 were remarkably increased, and the gene expression level of survivin significantly decreased in VPA treatment group. Conclusion VAP significantly inhibites xenografted Kasumi-1 tumor growth and induces tumor cell differentiation and apoptosis. The mecha- nism may be decrease of survivin gene expression, inhibition of nuclear expression of HDAC, promotion of histone protein acytelation level and acetylation of histone H3 within GM-CSF promoter region, and increase of GM-CSF transcription.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2011年第7期458-462,共5页 Chinese Journal of Hematology
基金 河北省自然科学基金(C2008000660)
关键词 白血病 组蛋白脱乙酰化酶 丙戊酸钠 细胞凋亡 肿瘤移植 Leukemia Histone deacetylase Valproic acid Apoptosis Xenograft tumor
  • 相关文献

参考文献9

  • 1[tug BA, l,azar MA. ETO interactitlg proteins. Oncogene, 2004,23:4270-4274.
  • 2Gottlicher M, Minucci S,Zhu P,et al. Valproic acid defines a novel edass of HDAC inhibitors inducing differentiation of transfornered cells. EMBO J, 2001,20:6969-6978.
  • 3Liu S, Klsovic RB, Vukosavljevic T, el al. Targeting AMLL/ETO- histone deacetylase repressor couq++lex: a novel mnechanism for val- proic acid-mediated gene expression and cellular difl'erentiation itl AMl+l/ETO-positive acute myeloid leukemia cells. J Pharmacol Exp Ther, 2007,321:953-960.
  • 4Wiehmann C, Chen L, Hemrich M,et al. Targeting the oligomer- izaLiovl domain of ETO ittterferes with RUNXL/ETO oneogenic activity in 1 ( 8 ; 21 ) -positive leukemic cells. Cancer Res, 2007,67 : 2280 -2289.
  • 5Redner RL, Watlg .l, Liu JM. Chvomatin remodeling arid letlkelni- a: new therapeutic paradigms. Blood, 1999,94:417-428.
  • 6赵蕾,张志华,朱翠敏,田文亮,郝长来.丙戊酸钠对Kasumi-1细胞细胞周期的阻滞作用及其机制探讨[J].中华血液学杂志,2008,29(12):802-805. 被引量:3
  • 7朱翠敏 帐志华 姜风云 等.组蛋白脱乙酰化酶抑制剂对sunli-1细胞血管新生相关因子表达的影响[J].中华血液杂志,:4664-69.
  • 8Palbsl T,Mueller BU,Harakawa N,et al AMLI-ETO xlownregulates the granuloeytic differentiation factor C.EBPalpha in 1(8:21)myeloid leukemia Nat Med ,2001,7:444-451.
  • 9Altieri DC New eirings in the Survivin neleorks Oncogene2008,27:6276-6284.

二级参考文献11

  • 1Gottlicher M, Minucci S, Zhu P, et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J,2001,20:6969-6978.
  • 2Trus MR, Yang L, Suarez Saiz F,et al. The histone deacelyase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells. Leukemia, 2005, 19 : 1161- 1168.
  • 3Catalano MG, Fortunati N, Puqliese M, et al. Valproic acid induces apoptosis and cell cycle arrest in poorly differentiated thyroid cancer cells. J Clin Endocrinol Metab,2005,90 : 1383-1389.
  • 4Larizza L, Magnani I, Beghini A. The Kasumi-1 cell line: a t(8; 21 ) -kit mutant model for acute myeloid leukemia. Leuk Lymphoma, 2005,46:247-255.
  • 5Motokura T, Bloom T, Kim HG,et al. A novel cyclin encoded by a bcl 1-linked candidate oncogene. Nature, 1991,350:512-515.
  • 6Milutinovic S, Knox JD, Szyf M. DNA methyltransferase inhibition induces the transcription of the tumor suppressor P21 ( WAF1/ CIP1/Sdil ). J Biol Chem, 2000,275 : 6353-6359.
  • 7Sakajiri S, Kumagai T, Kawamata N, et al. Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines. Exp Hematol,2005 ,33 :53-61.
  • 8Lavelle D,Chen YH, Hankewych M, et al. Histone deacetylase inhibitors increase P21^WAF1 and induce apoptosis of human myeloma cell lines independent of decreased IL-6 receptor expression. Am J Hemato1,2001,68 : 170-178.
  • 9Richon VM, Sandhoff TW, Rifkind RA, et al. Histone deacetylase inhibitor selectively induces P21 WAH expression and gene-associated histone acetylation. Proc Natl Acad Sci U S A,2000,97:10014- 10019.
  • 10Nebbioso A, Clarke N, Voltz E, et al. Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells. Nat Med,2005,11:77-84.

共引文献2

同被引文献47

  • 1Gttlicher M,Minucci S,Zhu P,et al.Valproic acid defines anovel class of HDAC inhibitors inducing differentiation oftransformed cells[J].EMBO,2001,20(24):6969-6978.
  • 2Minucci S,Nervi C,Lo Coco F,et al.Histonc deacetylases:acommon molecular target for differentiation treatment of acutemyeloid leukemias[J].Oncogene,2001,20(24):3110-3115.
  • 3Wichmann C,Chen L,Heinrich M,et al.Targeting theoligomerization domain of ETO interferes with RUNX1/ETOoncogenic activity in t(8;21)-positive leukemic cells[J].CancerRes,2007,67(5):2280-2289.
  • 4Hiramatsu A,Miwa H,Shikami M,et al.Disease-specificexpression of VEGF and its receptors in AML cells:possibleautocrine pathway of VEGF/type1receptor of VEGF in t(15;17)AML and VEGF/type2receptor of VEGF in t(8;21)AML[J].Leuk Lymphoma,2006,47(1):89-95.
  • 5Imai N,Shikami M,Miwa H,et al.t(8;21)acute myeloidleukaemia cells are dependent on vascular endothelial growthfactor(VEGF)/VEGF receptor type2pathway and phospho-rylation of Akt[J].Br J Haematol,2006,135(5):673-682.
  • 6SHAPIRO G I. Cyclin-dependent kinase pathways as targets for cancer treatment[J].{H}Journal of Clinical Oncology,2006,(11):1770-1783.
  • 7LEE Y M,SICINSKI P. Targeting cyclins and cyclin-dependent kinases in cancer:lessons from mice,hopes for therapeutic applications in humans[J].{H}CELL CYCLE,2006,(18):2110-2114.
  • 8OGINO S,NOSHO K,SHIMA K. p21 Expression in colon cancer and modifying effects of patient age and body mass index on prognosis[J].{H}Cancer Epidemiology Biomarkers & Prevention,2009,(09):2513-2521.
  • 9JOHNSON G G,SHERRINGTON P D,CARTER A. A novel type of p53 pathway dysfunction in chronic lymphocytic leukemia resulting from two interacting single nucleotide polymorphisms within the p21 gene[J].{H}CANCER RESEARCH,2009,(12):5210-5217.
  • 10BELLUCCI L,DALVAI M,KOCANOVA S. Activation of p21 by HDAC inhibitors requires acetylation of H2A.Z[J].PLoS One,2013,(01):e54102.

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部